Today’s top gainers include the company CR Bard Inc. (NYSE:BCR) which is in the industry Medical Instruments & Supplies, gaining -0.17% today. In the last week its performance is 3.80%, and 13.53% for the past quarter. Currently, CR Bard Inc., BCR has a target price of 229.64, so today’s gain of -0.17% is a significant step towards its target price. The GAP today is therefore 0.00%.
CR Bard Inc. (NYSE:BCR), has a market cap of 17242.39, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 90.70%.
At the current price of 234.75, it has a dividend yield of 0.44%, and its target price is 229.64. This is with a profit margin of *TBA, and total debt/equity of 1.14. CR Bard Inc. (NYSE:BCR) has a P/E of 103.96, as well as a forward P/E of 20.85.
With a current EPS of 2.26, and a forecasted EPS growth for next year at 10.90%,CR Bard Inc. (NYSE:BCR) has had a EPS growth for the past five years at -19.80%. For the next five years EPS growth is projected to be 10.80%.
Performance for the year is 37.74%. Since its IPO date on 04/06/1983, the total performance to date is 24.23%.
Volume today for CR Bard Inc. (NYSE:BCR), is 545057, while its average volume is 466.15. Whilst the total gain today was -0.17%, it did have a day high of -0.17%.
Volatility for this week has been at 1.49%, and 1.42% for the month. The 52-week low for CR Bard Inc., BCR has been 39.54%, while the 52-week-high has reached -0.17%.
Looking at its return of investments, which is 6.40%, and its return on assets is *TBA. CR Bard Inc. (NYSE:BCR) has an operating margin of *TBA. With a sales growth of 6.60% quarter over quarter. Bearing in mind that CR Bard Inc., BCR is in the sector Healthcare, its long-term debt/equity is 0.78, and has a current ratio of 1.5 and 1.2 for quick ratio.
So what is the value of CR Bard Inc.? Well its PEG is 9.62, and the P/S is 4.97, along with a P/B of 11.9. Meanwhile it has a p/cash of 22.54.